Health
IBM Research develops new macromolecule that could counter antibiotic resistance – Yahoo Finance Australia
There are other persistent, grave health crises brewing besides the ongoing COVID-19 pandemic: Antibiotic resistance is one, and the troubling trend is that it’s on the rise, leading to an increase in so-called “superbugs” that are difficult to treat. IBM R…
There are other persistent, grave health crises brewing besides the ongoing COVID-19 pandemic: Antibiotic resistance is one, and the troubling trend is that it’s on the rise, leading to an increase in so-called “superbugs” that are difficult to treat. IBM Research, working in partnership with Singapore’s Institute of Bioengineering and Nanotechnology, has developed a synthetic macromolecule polymer that can potentially be used to significantly increase the effectiveness of existing antibiotics, …
-
Noosa News22 hours agoBrisbane’s new bus timetable sees journey times decrease by two minutes in first three months
-
Noosa News24 hours agoGovernment auditors suspected lab was conducting shonky tests on infrastructure projects
-
Business21 hours agoWhat it means for shareholders
-
Business22 hours agoThe high-conviction ASX stocks I’d buy and hold forever
